ALLK Allakos Inc Net earnings per share growth forecast for next year
Allakos Inc. relies on stable demand in chronic allergy therapy thanks to the patent protection of its formulas. The n+1 net income per share growth projection on GURU.Markets reflects the current business adaptation, where the value is fixed at 36.80. Lirentelimab trials are driving growth, although management is currently optimizing headcount and updating the R&D strategy to restore the confidence of institutional investors.
Comprehensive metric breakdowns and analytics for Allakos Therapeutics (ALLK)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
ALLK - Company Net Income|Expected Profit Allakos Inc.|ALLK - Business Payback Period|Projected Price to Earnings allakos.com|ALLK - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple ALLK|ALLK - Operating income before deduction of amortization|Earnings per share for the last twelve months Allakos|ALLK - Earnings per share for the last 12 months|Quarterly EPS earnings growth allakos.com|ALLK - Net earnings per share growth this year|Expected earnings per share growth for next year Allakos Inc.
- total revenue and sales volume data:
Summary company analysis:allakos.com, ALLK
This indicator reflects the consensus forecast for the average annual earnings growth over the coming twelve-month period, allowing for an assessment of the fundamental capitalization potential through future cash flows. By analyzing the valuation of forward net income growth rates, an investor can align market expectations with the progress in updating the immunological portfolio of Allakos Inc. (ALLK), which is critical for restoring confidence following past clinical failures.
Main competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|Pharming Group (PHAR) - Net earnings per share growth forecast for next year|Nektar Therapeutics Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year UPB|Zenas Bio (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Consensus forecast of earnings per share growth for next year septerna.com (SEPN)|PVLA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Savara Inc SVRA|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Holdings Inc.)|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Earnings growth forecast for next year Aerovate Therapeutics, Inc. (JBIO)|Earnings growth forecast for next year ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Expected net earnings per share growth next year|tizianalifesciences.com - Earnings growth forecast for next year|CABA (Cabaletta Bio, Inc.) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics Inc|Eledon (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year ZURA (zurabio.com)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ikenaoncology.com (IMA) - Expected earnings per share growth for next year|Shattuck Labs (STTK) - Net earnings per share growth forecast for next year|EQ - Consensus forecast of earnings per share growth for next year|CNTB (connectbiopharm.com) - Earnings growth forecast for next year|IMUX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Atara Biotherapeutics, Inc. (ATRA)|Consensus forecast of earnings per share growth for next year InflaRx NV|Earnings growth forecast for next year XFOR (X4 Pharmaceuticals)|Earnings growth forecast for next year Adicet Bio ACET|CELU: Expected earnings per share growth for next year|Expected earnings per share trend next year INMB (INmune Bio)|Barinthus Bio (BRNS) - Net earnings per share growth forecast for next year|Kezar Life Sciences (KZR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year sabbiotherapeutics.com|Earnings growth forecast for next year Akari Therapeutics Plc|Net earnings per share growth forecast for next year Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year GeoVax Corp GOVX|Consensus forecast of earnings per share growth for next year Edesa Biotech Corp (EDSA)|IBIO: Expected earnings per share growth for next year|Expected earnings per share trend next year CARM (carismatx.com)|XTLB: Earnings growth forecast for next year|BOLT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year HCWB|Expected earnings per share growth for next year Aptevo Therapeutics Inc. (APVO)|Earnings growth forecast for next year AIM|ADTX: Net earnings per share change forecast for next year|GRI Bio - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year XORTX Therapeutics Inc (XRTX)|HIND: Expected earnings per share growth for next year|Revelation Biosciences (REVB) - Expected earnings per share growth for next year|Indaptus Therapeutics, Inc. (INDP) - Net earnings per share growth forecast for next year|SCNI - Consensus forecast of earnings per share growth for next year|CALI (CalciMedica) - Earnings growth forecast for next year|Earnings growth forecast for next year affimed.com|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year iteostherapeutics.com ITOS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
